Type 2 Diabetes Trial, Recruiting NCT07216118 Sponsor: University of Pittsburgh Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07216118
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For the young person:

  • Between 13 and 22 years old
  • Has been diagnosed with type 2 diabetes
  • Currently receiving care at UPMC Children's Hospital of Pittsburgh
  • Able to give their agreement to take part in the study

For the caregiver:

  • An adult aged 18 or older who identifies as a primary caregiver of a young person aged 13 to 22 with type 2 diabetes
  • The young person in their care has also agreed to take part in the study
  • Able to give their consent to participate

Note: A young person and their caregiver must join together as a pair.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The young person or caregiver is not able to complete study questionnaires written in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary Ellen Vajravelu, MD MSHP, University of Pittsburgh

Phone: 412-692-6533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 April 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of Intervention: Health-Related Social Needs Screener; Acceptability of Intervention: Tailored Approach to Address Health-Related Social Needs; Acceptability of Intervention: Universal Empowerment Approach to Address Health-Related Social Needs; Acceptability of Intervention: Text Messages to Address Health-Related Social Needs; Acceptability of Intervention: Community Health Workers to Address Health-Related Social Needs; Fidelity of Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov